Hetrombopag
Hetrombopag is a pharmaceutical drug for the treatment of thrombocytopenia and anemia.
It is a non-peptide small‐molecule thrombopoietin receptor agonist.
In China, it is approved for second-line treatment for primary immune thrombocytopenic purpura and severe aplastic anemia in adults.